The relationship of doxorubicin binding to membrane lipids with drug resistance

Cancer Lett. 1992 Apr 15;63(2):109-16. doi: 10.1016/0304-3835(92)90060-9.

Abstract

Doxorubicin (DOX, Adriamycin) binds with high affinity to cellular membranes inflicting multiple lesions which are believed to be important in DOX-mediated neoplastic cell death. Using fluorescence and radioactive [14-14C-14]DOX assays for DOX, we have measured the partitioning of DOX between the cytosolic and membrane fractions of erythrocytes and of DOX-sensitive (V-79) and -resistant (LZ) Chinese hamster lung fibroblast cells. In both erythrocytes and fibroblasts, a significant fraction of DOX was associated with the membrane fraction. More significantly, the quantity of lipid-bound DOX in the fibroblasts correlated with the cell's susceptibility to DOX. The significance of these findings in the context of existing knowledge about DOX-membrane interactions is discussed.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Biological Transport
  • Cell Line
  • Cell Membrane / metabolism*
  • Cricetinae
  • Cricetulus
  • Cytosol / metabolism
  • Doxorubicin / metabolism*
  • Doxorubicin / pharmacology
  • Drug Resistance / physiology*
  • Erythrocyte Membrane / metabolism*
  • Humans
  • Kinetics
  • Membrane Lipids / blood
  • Membrane Lipids / metabolism*

Substances

  • Membrane Lipids
  • Doxorubicin